LobbyingNRX Pharmaceuticals lobbying by quarter
NRX Pharmaceuticals NRXP's latest lobbying report covers Q2 2026, at $75K. The four quarters Q3 2025–Q2 2026 total $265.3K. Its first report covers Q3 2025; the issues it reports most are Pharmacy.
NRX PharmaceuticalsNRXP
- Latest quarter
- $75K
- Q2 2026 · 1 reports
- Last 12 months
- $265.3K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $40.3K | 1 |
| Q4 2025 | $75K | 1 |
| Q1 2026 | $75K | 1 |
| Q2 2026 | $75K | 1 |
Policy issues the reports name
- Pharmacy4 reports
A report that names several issues counts once for each.
Who was lobbied
- Health & Human Services, Dept of (HHS)4 reports
- Executive Office of the President (EOP)2 reports
- HOUSE OF REPRESENTATIVES2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Continental Strategy | $265.3K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CRAIG PATRICK CARBONE | Former Chief of Staff to Marco Rubio | Q2 2026 |
| HAYES KENNETH HEREDIA | Legislative Assistant to Senator Cindy Hyde-Smith | Q2 2026 |
| TIMOTHY COSTA | Former Chief of Staff to Dan Meuser | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Continental Strategy | $75K |
| 04/18for Q1 | Continental Strategy | $75K |
| 01/19for Q4 2025 | Continental Strategy | $75K |
| 25/10/20for Q3 2025 | Continental Strategy | $40.3K |
| 25/08/28for Q3 2025 | Continental Strategy | Under $5,000 |